Viewing Study NCT00812058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-02-25 @ 6:44 PM
Study NCT ID: NCT00812058
Status: COMPLETED
Last Update Posted: 2011-01-17
First Post: 2008-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
Sponsor: Repligen Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bipolar I Depression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bipolar Depression View
None Bipolar Disease View
None Bipolar Disorder View
None Bipolar View
None Manic Depression View
None Manic Depressive Disorder View